Cytokinetics Inc (NASDAQ:CYTK)

6.22
Delayed Data
As of May 22
 -0.05 / -0.80%
Today’s Change
3.05
Today|||52-Week Range
8.61
-22.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$240.8M

Company Description

Cytokinetics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its current research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle. Cytokinetics was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Contact Information

Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco California 94080
P:(650) 624-3000
Investor Relations:
(650) 624-3060

Employees

Shareholders

Individual stakeholders7.69%
Other institutional43.61%
Mutual fund holders15.48%

Top Executives

Robert I. BlumPresident, Chief Executive Officer & Director
Sharon A. BarbariChief Financial Officer, Secretary & Executive VP
Fady Ibraham MalikSenior Vice President-Research & Development
Andrew A. WolffChief Medical Officer & Senior Vice President
Bonnie A. CharpentierSenior VP-Regulatory Affairs & Compliance

To view my watchlist

Not a member yet?

Sign up now for a free account